However, aberrant activation and deregulation of SHH signaling lead to tumor initiation and progression, and promote cancer stemness, epithelial-mesenchymal transitions (EMT), drug resistance, invasion of surrounding tissues, and metastasis to distant organs for secondary tumor formation in multiple tumor types [9,10]. The gene discussed is SHH; the disease is cancer.